Deep Learning-Based Drug Repurposing Using Knowledge Graph Embeddings and GraphRAG
George, H.; Baratam, G.; DS, D.
Show abstract
Drug repurposing has become a crucial strategy to accelerate drug discovery and reduce development costs. Conventional drug development is time consuming and expensive; it often takes more than a decade and billions of dollars to bring a new drug into the market. To address these challenges, this work puts forward a deep learning-based strategy for drug repurposing using knowledge graph embeddings and Graph-based Retrieval-Augmented Generation. The system leverages pretrained TransE model embeddings on the Drug Repurposing Knowledge Graph (DRKG) that includes over 97,000 biomedical entities and 4.4 million relationships. In the proposed framework, knowledge graph embeddings have been combined with LLMs to provide explainable predictions of drug repurposing. The system processes natural language queries about diseases, retrieves relevant drug candidates by deep learning based scoring, and generates interpretable explanations of drug disease relationships. This research combines PyTorch based embedding operations with NetworkX graph analysis and OpenAIs GPT models for an efficient, accurate, and explainable solution to automated drug repurposing, thus helping researchers and clinicians identify novel therapeutic applications for existing drugs.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- DTI-Voodoo: machine learning over interaction networks and ontology-based background knowledge predicts drug-target interactions 96%
- Design and application of a knowledge network for automatic prioritization of drug mechanisms 96%
- ARAX: a graph-based modular reasoning tool for translational biomedicine 95%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Artemis: Harnessing Knowledge Graphs for Next-Generation Drug Target Prioritization 95%
- TCMM: A Unified Database for Traditional Chinese Medicine Modernization and Therapeutic Innovations 93%
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.